Declines in Low Birth Weight and Preterm Birth Among Infants Who Were Born to HIV-Infected Women During an Era of Increased Use of Maternal Antiretroviral Drugs: Pediatric Spectrum of HIV Disease, 1989–2004
暂无分享,去创建一个
[1] B. Luke,et al. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? , 2006, The Journal of infectious diseases.
[2] J. Martin,et al. Births: preliminary data for 2004. , 2005, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[3] C. Zorrilla,et al. Protease Inhibitor Use in 233 Pregnancies , 2005, Journal of acquired immune deficiency syndromes.
[4] D. H. Watts,et al. Improved Obstetric Outcomes and Few Maternal Toxicities Are Associated With Antiretroviral Therapy, Including Highly Active Antiretroviral Therapy During Pregnancy , 2005, Journal of acquired immune deficiency syndromes.
[5] M. Newell,et al. Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe , 2004, AIDS.
[6] J. Bartlett,et al. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to reduce Perinatal HIV-1Transmission in the United States , 2003 .
[7] Jeffrey L. Jones,et al. Trends in Pregnancy Rates Among Women With Human Immunodeficiency Virus , 2004, Obstetrics and gynecology.
[8] C. Benedetto,et al. INCREASED RISK OF ADVERSE PREGNANCY OUTCOMES IN HIV-INFECTED WOMEN TREATED WITH HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN EUROPE , 2004 .
[9] M. Lindegren,et al. Increasing Trend of Cesarean Deliveries in HIV‐Infected Women in the United States From 1994 to 2000 , 2003, Journal of acquired immune deficiency syndromes.
[10] M. Newell,et al. Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. , 2003, Journal of acquired immune deficiency syndromes.
[11] Deren Bader,et al. US birth weight/gestational age-specific neonatal mortality: 1995-1997 rates for whites, hispanics, and blacks. , 2003, Pediatrics.
[12] J. Church. Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV-1 , 2002, Pediatrics.
[13] M. Hughes,et al. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. , 2002, The New England journal of medicine.
[14] K. Schoendorf,et al. Changing patterns of low birthweight and preterm birth in the United States, 1981-98. , 2002, Paediatric and perinatal epidemiology.
[15] M. Lindegren,et al. Trends in HIV testing among pregnant women: United States, 1994-1999. , 2001, American journal of public health.
[16] Swiss Mother. Combination antiretroviral therapy and duration of pregnancy , 2000, AIDS.
[17] K. Ethier,et al. Infant birth weight among women with or at high risk for HIV infection: the impact of clinical, behavioral, psychosocial, and demographic factors. , 2000, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[18] D. Harris,et al. Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine , 2000, AIDS.
[19] J. Ward,et al. Trends in perinatal transmission of HIV/AIDS in the United States. , 1999, JAMA.
[20] J. Read,et al. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: a meta-analysis of 15 prospective cohort studies: the International Perinatal HIV Group , 1999 .
[21] F. Parazzini. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial , 1999, The Lancet.
[22] J. Pitt,et al. Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: a report of the women and infants transmission study. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[23] P. Falconieri,et al. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 , 1999 .
[24] B. Hirschel,et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects , 1998, AIDS.
[25] P Bacchetti,et al. Risk of Low Birth Weight Infants Among Black and White Parents , 1998, Obstetrics and gynecology.
[26] W. Hauck,et al. Improved Birth Outcomes Associated With Enhanced Medicaid Prenatal Care in Drug‐Using Women Infected With the Human Immunodeficiency Virus , 1998, Obstetrics and gynecology.
[27] R. Steketee,et al. Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV , 1998, AIDS.
[28] R. Sperling,et al. Incidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers. The Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Infection Study Group. , 1997, The Journal of pediatrics.
[29] V. Rauh,et al. Ethnic differences in birthweight: the role of lifestyle and other factors. , 1997, American journal of public health.
[30] L. Markson,et al. Association of maternal HIV infection with low birth weight. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[31] W. Hauck,et al. Prenatal care and birth outcomes of a cohort of HIV-infected women. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[32] L. Kalish,et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child , 1996, The New England journal of medicine.
[33] H. Barnhart,et al. Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. , 1996, Pediatrics.
[34] Reduction of maternal‐infant transmission of human immunodeficiency virus type 1 with zidovudine treatment , 1995 .
[35] D. Satcher. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. , 1995, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[36] N. Day,et al. The Epidemiology of Alcohol, Marijuana, and Cocaine Use Among Women of Childbearing Age and Pregnant Women , 1993, Clinical obstetrics and gynecology.
[37] S. Seiden,et al. Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. , 1993, Journal of acquired immune deficiency syndromes.
[38] J. Desenclos,et al. Characteristics of mothers of live infants with congenital syphilis in Florida, 1987-1989. , 1992, American journal of epidemiology.
[39] M C McCormick,et al. The contribution of low birth weight to infant mortality and childhood morbidity. , 1985, The New England journal of medicine.
[40] R. Plackett,et al. Principles of regression analysis , 1961 .